Enhancing GARP expression, and its accompanying immunosuppression, may be beneficial for the treatment of autoimmunity and transplant rejection, whereas downregulating GARP expression may aid in the improvement of anti-tumor immune responses (Figure 1D). This evidence concerns the gene LRRC32 and Autoimmunity.